Year archive

EQL Pharma AB — 2024 filings

All 12 regulatory filings released by EQL Pharma AB (EQL) in 2024, sourced directly from the official regulator.

12 Filings

2024 Period

2024 filings (12)

Filing	Released	Lang
Correction: EQL Pharma AB (publ) signs an asset purchase agreement in respect of the acquisition of a portfolio with original pharmaceuticals M&A Activity	2024-12-10	English
Rättelse: EQL Pharma AB (publ) ingår ett inkråmsöverlåtelseavtal avseende förvärv av en portfölj med originalläkemedel Capital/Financing Update	2024-12-10	Swedish
EQL Pharma AB (publ) ingår ett inkråmsöverlåtelseavtal avseende förvärv av en portfölj med originalläkemedel M&A Activity	2024-12-10	Swedish
EQL Pharma AB (publ) signs an asset purchase agreement in respect of the acquisition of a portfolio with original pharmaceuticals M&A Activity	2024-12-10	English
Interim / Quarterly Report 2024 Interim / Quarterly Report H1 2024	2024-11-06	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report H1 2025	2024-11-06	English
Kommuniké från årsstämma i EQL Pharma AB den 19 augusti 2024 AGM Information	2024-08-19	Swedish
Bulletin from the annual general meeting in EQL Pharma AB on 19 August 2024 AGM Information	2024-08-19	English
Interim / Quarterly Report 2024 Interim / Quarterly Report Q1 2024	2024-08-08	Swedish
Interim / Quarterly Report 2024 Interim / Quarterly Report Q2 2024	2024-08-08	English
Notice of annual general meeting in EQL Pharma AB AGM Information	2024-07-16	English
Kallelse till årsstämma i EQL Pharma AB AGM Information	2024-07-16	Swedish